News | Nice & Green

News

November 09, 2021

Nice & Green participates in the IPO of the French biotech MaaT Pharma now listed on Euronext Paris

Nice & Green, the Swiss investment firm, announces today its participation in the Initial Public Offering (IPO) operation of the French biotech MaaT P...

Read more

November 04, 2021

Nice & Green enters a 4-year investment partnership with EEMS Italia SpA which will consolidate its presence in the Energy Transition market by 2026

Nice & Green, the Swiss investment firm, announced today the signing of a 4-year investment agreement of up to EUR 20’450’000 with EEMS Italia SpA (BI...

Read more

October 05, 2021

Nice & Green provides funding of 5.4 million euros to Marinomed Biotech AG as part of the plans to advance its scientific and clinical programs

Nice & Green, the Swiss investment firm, announces today the signing of a new investment agreement of up to 5.4 million euros with Marinomed Biotech A...

Read more

August 23, 2021

Nice & Green increases its stake in Napster Group PLC to 12.308 % and becomes the largest shareholder

Nice & Green, the Swiss investment firm, is pleased to announce that it has increased its stake in Napster Group PLC, the market leader for music ente...

Read more

June 02, 2021

Nice & Green announces the termination of the investment agreement signed with Goodbye Kansas Group (formerly Bublar Group)

Based on mutual understanding between Nice & Green and Goodbye Kansas Group, Nice & Green announces the termination of an investment agreement of up t...

Read more

May 14, 2021

Tiscali obtains new funding for implementing its 2021-2023 business plan through an investment agreement with Nice & Green

Tiscali (TIS.MI), the Italian pioneering telecommunications company with the highest fibre coverage available in Italy, has secured a funding commitme...

Read more

April 14, 2021

Nice & Green and Napster Group PLC have decided to significantly increase the pace of the financing program.

Napster Group PLC (AIM:NAPS), a leading music company and operator of the MelodyVR and Napster platforms, is pleased to announce that it has secured a...

Read more

April 14, 2021

Nice & Green SA is a new member of Swiss Biotech Association for the year 2021

Nice & Green SA is excited to announce its recent membership to Swiss Biotech Association for the year 2021....

Read more

March 31, 2021

Nice & Green, a European leading alternative financing company, announced a minority growth investment by Artemis Group, owned by Swiss entrepreneur Michael Pieper

Nice & Green SA (“Nice & Green”), an independent Switzerland-based provider of innovative alternative financing solutions for small and mid-sized list...

Read more

February 08, 2021

MelodyVR, a leading music company, announced an investment of £6.48 million by Nice & Green to support the development of its new disruptive app

MelodyVR Group PLC (AIM:MVR), a leading music company and operator of the MelodyVR and Napster platforms, who recently announced its intention to chan...

Read more

January 27, 2021

Rapid Nutrition attracts USD 1 million investment with Swiss company Nice & Green to fund its growth strategy

Rapid Nutrition (RAP: SW, OTCQB: RPNRF) a natural healthcare company focused on natural nutrition, diet management and life science products, announce...

Read more

January 14, 2021

Cyan Digital Security, one of the world’s leading IT security expert for over 15 years, secures financing line of up to EUR 8.4 million with Nice & Green

The Management Board of cyan AG, a leading globally active provider of intelligent IT security solutions and telecom services, resolved a "Convertible...

Read more

January 13, 2021

To finance the acquisition of a manufacturer of implants for spine surgery, Implanet has signed for the fourth time a convertible bond line with its long-term financial partner, Nice & Green

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and...

Read more

December 21, 2020

Amoéba, one of the major players in French biotech, renews for the third time a financing line of up to 23 million euros with Nice & Green to support its development

AMOEBA (FR0011051598 - ALMIB), producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product...

Read more

December 15, 2020

FacePhi, a world leader in biometric solutions for identity verification, renews its contract with Nice & Green and obtains funding for 20 million euros to enhance its growth plan

The Spanish technology company FacePhi has just concluded a second investment agreement with the Swiss firm Nice & Green worth up to 20 million euros....

Read more

December 08, 2020

Evolva, the Swiss biotech company, researching, developing and commercializing nature-based ingredients, has renewed its trust in Nice & Green by securing another CHF 12 million investment

Evolva (SIX:EVE), the Swiss biotech company focused on the research, development and commercialization of products based on nature, has announced that...

Read more

October 28, 2020

Bublar Group enters into financing agreement of up to SEK 50.4 million

Bublar Group enters into a flexible convertible loan agreement with Swiss Nice & Green S.A. of up to SEK 50.4 million. The agreement allows Bublar Gro...

Read more

October 04, 2020

Artificial Solutions agrees a flexible convertible notes funding program providing up to SEK 60 million to support accelerated growth

Artificial Solutions® International AB (publ) (“Artificial Solutions”) (SSME:ASAI) the leading specialist in enterprise-strength conversational AI, ha...

Read more

August 06, 2020

By signing a EUR 6 million financing agreement with Itway, a high- tech Italian company, Nice & Green confirms its policy to invest in and finance selected small and mid-cap with high potential.

By signing a EUR 6 million financing agreement with Itway, a high- tech Italian company, Nice & Green confirms its policy to invest in and finance sel...

Read more

June 29, 2020

Evolva signs a CHF 12 million investment with Swiss company Nice & Green to fund future growth

Evolva (SIX:EVE), the Swiss biotech company, today announced that it has entered into an agreement for the issuance and subscription of convertible no...

Read more

June 25, 2020

SpineGuard sécurise un financement en fonds propres de 2,4 M€ sur 12 mois avec Nice & Green

SpineGuard (FR0011464452 – ALSGD, éligible PEA-PME), entreprise innovante qui conçoit, développe et commercialise des dispositifs médicaux destinés à ...

Read more

May 18, 2020

WISeKey signs a CHF 10.0 million investment with Swiss investment firm Nice & Green to finance its new IoT Division in Europe and future M&A opportunities

WISeKey signs a CHF 10.0 million investment with Swiss investment firm Nice & Green to finance its new IoT Division in Europe and future M&A opportuni...

Read more

March 23, 2020

Moberg Pharma enters financing agreement of up to SEK 216 million for further investments in MOB-015

Moberg Pharma AB (publ) announces today that the company has entered into a convertible note agreement with Nice & Green S.A. (“N&G”), contingent on a...

Read more

September 18, 2019

FacePhi receives a 4 million euros investment from Nice&Green to strengthen its growth

The investment agreement will accelerate the growth of the company, specialized in biometrics for the fintech sector, in the American and Asian market...

Read more

July 15, 2019

Morning Note

SpineGuard posted last Thursday Q2 revenues of EUR1.80m (vs EUR1.86m in Q2 2018), down -3%. Currency impact is limited compared to Q1 (-6% on a like-f...

Read more

May 09, 2019

Kuros Biosciences enters convertible bond financing agreement for up to CHF 5 million

Kuros Biosciences (SIX: KURN) today announced that it has entered into a convertible bond financing agreement with Nice & Green S.A. for up to a maxim...

Read more

November 09, 2018

Implanet met en place avec la société Nice & Green une ligne de financement obligataire incluant un programme d’intéressement

Bordeaux, Boston, le 9 novembre 2018 – 19h00 - IMPLANET, société de technologies médicales spécialisée dans les implants vertébraux et les impla...

Read more

September 13, 2018

SpineGuard obtient de nouveaux financements à hauteur de 9 millions d’euros

PARIS et SAN FRANCISCO, le 13 septembre 2018 – 18h00 (CEST) – SpineGuard, entreprise innovante qui conçoit, développe et commercialise des instrumen...

Read more

July 26, 2018

AMOEBA ANNONCE LA MISE EN PLACE D’UNE LIGNE DE FINANCEMENT OBLIGATAIRE DE 6 M€ AVEC PROGRAMME D’INTERESSEMENT (OCAPI)

Lyon (France), le 26 juillet 2018 - AMOEBA, producteur d’un biocide biologique capable d’éliminer le risque bactérien dans l’eau a décidé de se do...

Read more

June 15, 2018

Onxeo Implements an Equity Line Financing Including an Incentive Program with Nice & Green SA

Paris (France), June 15, 2018 – 6.30 pm CEST - Onxeo S.A., a biotechnology company specializing in the development of innovative drugs in oncology, in...

Read more

June 11, 2018

Theraclion met en place un financement en fonds propres de 3,6 M€ sur 12 mois avec NICE & GREEN

Malakoff, le 11 juin 2018 – THERACLION, société spécialisée dans l’équipement médical innovant dédié à l’échothérapie, annonce aujourd'hui ...

Read more

December 29, 2017

Saniona Establish Equity Financing of up to SEK 144 million

Saniona AB, a leading biotech company in the field of ion channels, announced today that it has entered into a convertible notes funding agreement wit...

Read more

December 01, 2017

Modification du calendrier d’émission de la ligne de financement obligataire de 2,4 M€ avec programme d’intéressement (OCAPI)

PARIS, SAN FRANCISCO, le 1er décembre 2017 – 18h00 CET - SpineGuard, entreprise innovante qui conçoit, développe et commercialise des instruments m...

Read more

October 02, 2017

SpineGuard establishes two-year €2.4m Convertible Bonds Facility with Nice & Green

PARIS and SAN FRANCISCO, Oct. 2, 2017 – 6:00 PM CET – SpineGuard, an innovative company that designs, develops, and markets disposable medical devices...

Read more

For our latest update on deals and market insights